Drug Development - Targeting HER2 beyond Trastuzumab

被引：0
|
作者：
Spector, N. L. [1 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-PL2-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PL2-1
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Targeting HER2 in lung cancers: Evolving treatment landscape and drug development strategies
    Reinhorn, Daniel
    Moskovitz, Mor
    Tap, William D.
    Li, Bob T.
    CANCER, 2025, 131
  • [12] Development of 64Cu-NOTA-Trastuzumab for HER2 Targeting: A Radiopharmaceutical with Improved Pharmacokinetics for Human Studies
    Woo, Sang-Keun
    Jang, Su Jin
    Seo, Min-Jung
    Park, Ju Hui
    Kim, Byoung Soo
    Kim, Eun Jung
    Lee, Yong Jin
    Lee, Tae Sup
    An, Gwang Il
    Song, In Ho
    Seo, Youngho
    Kim, Kwang Il
    Kang, Joo Hyun
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (01) : 26 - 33
  • [13] Beyond Primary HER2 Expression: Trastuzumab Deruxtecan's Efficacy in Brain Metastasis
    Das, Glori
    Wong, Stephen T. C.
    Zhao, Hong
    CANCERS, 2024, 16 (20)
  • [14] Beyond HER2: Targeting the ErbB receptor family in breast cancer
    Drago, Joshua Z.
    Ferraro, Emanuela
    Abuhadra, Nour
    Modi, Shanu
    CANCER TREATMENT REVIEWS, 2022, 109
  • [15] Use of total HER2 and HER2 homodimer levels to predict response to trastuzumab
    Leitzel, K.
    Lipton, A.
    Koestler, W.
    Fuchs, E.
    Ali, S. M.
    Weidler, J.
    Wu, Y.
    Sperinde, J.
    Huang, W.
    Bates, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [16] Targeting HER2 as a therapeutic strategy for breast cancer: a paradigmatic shift of drug development in oncology
    De Laurentiis, M.
    Cancello, G.
    Zinno, L.
    Montagna, E.
    Malorni, L.
    Esposito, A.
    Pennacchio, R.
    Silvestro, L.
    Giuliano, M.
    Giordano, A.
    Caputo, F.
    Accurso, A.
    De Placido, Sabino
    ANNALS OF ONCOLOGY, 2005, 16 : 7 - 13
  • [17] Targeting HER2 in 2015
    Piccart-Gebhart, M.
    Zardavas, D.
    BREAST, 2015, 24 : S23 - S23
  • [18] Targeting HER2 epitopes
    Pal, Sumanta Kumar
    Pegram, Mark
    SEMINARS IN ONCOLOGY, 2006, 33 (04) : 386 - 391
  • [19] HER2 signaling pathway and trastuzumab cardiotoxicity
    Criscitiello, Carmen
    Curigliano, Giuseppe
    FUTURE ONCOLOGY, 2013, 9 (02) : 179 - 181
  • [20] Trastuzumab targeting of HER2 upregulates miRNA-194 and downregulates profilin 2 and DNMT3A in HER2 positive breast cancer
    Le, Xiao-Feng
    Wu, Yun
    Spizzo, Riccardo
    Yoo, Suk-Young
    Wang, Jing
    Calin, George A.
    Bast, Robert C.
    CANCER RESEARCH, 2011, 71
12345